Results 41 to 50 of about 136,484 (249)

Rayleigh Distribution Revisited Via Extension of Jeffreys Prior Information and a New Loss Function

open access: yesRevstat Statistical Journal, 2011
In this paper we present Bayes estimators of the parameter of the Rayleigh distribution, that stems from an extension of Jeffreys prior (Al-Kutubi (2005)) with a new loss function (Al-Bayyati (2002)).
Sanku Dey , Tanujit Dey
doaj   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

Bivariate power Lomax distribution with medical applications.

open access: yesPLoS ONE, 2023
In this paper, a bivariate power Lomax distribution based on Farlie-Gumbel-Morgenstern (FGM) copulas and univariate power Lomax distribution is proposed, which is referred to as BFGMPLx.
Maha E Qura   +3 more
doaj   +1 more source

A general theory for preferential sampling in environmental networks

open access: yes, 2019
This paper presents a general model framework for detecting the preferential sampling of environmental monitors recording an environmental process across space and/or time.
Shaddick, Gavin   +2 more
core   +1 more source

An extensive survey of the estimation of uncertainties from missing higher orders in perturbative calculations [PDF]

open access: yes, 2014
We consider two approaches to estimate and characterise the theoretical uncertainties stemming from the missing higher orders in perturbative calculations in Quantum Chromodynamics: the traditional one based on renormalisation and factorisation scale ...
Bagnaschi, Emanuele   +3 more
core   +2 more sources

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Statistical Inferences of Type-II Progressively Hybrid Censored Fuzzy Data with Rayleigh Distribution

open access: yesAustrian Journal of Statistics, 2018
This article presents the procedures for the estimation of the parameter of Rayleigh distribution based on Type-II progressive hybrid censored fuzzy lifetime data.
Ankita Chaturvedi   +2 more
doaj   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

Statistical Analysis and Theoretical Framework for a Partially Accelerated Life Test Model with Progressive First Failure Censoring Utilizing a Power Hazard Distribution

open access: yesMathematics, 2023
Monitoring life-testing trials for a product or substance often demands significant time and effort. To expedite this process, sometimes units are subjected to more severe conditions in what is known as accelerated life tests.
Amel Abd-El-Monem   +4 more
doaj   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy